Brief: Concord Biotech Invests $1 Million In Palvella Therapeutics
12/12/2024 06:34
Dec 12 (Reuters) - Concord Biotech Ltd CONB.NS :
* CONCORD BIOTECH LTD - INVESTS $1 MILLION IN PALVELLA
THERAPEUTICS
Source text: ID:nBSE7rWrnV
Further company coverage: CONB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval